CD14+CD16+ monocyte subpopulation in Kawasaki disease

Clinical and Experimental Immunology

Volumn 121, Issue 3, 2000, Pages 566-570

  Katayama, K ^a   Matsubara, T ^a,b   Fujiwara, M ^a   Koga, M ^a   Furukawa, S ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD14+CD16+ monocytes; IL 10; Kawasaki disease; Severe bacterial infection

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12;

ACUTE DISEASE; ARTICLE; BACTERIAL INFECTION; CELL SUBPOPULATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; IMMUNOREGULATION; INFANT; INFLAMMATION; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MALE; MONOCYTE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL;

ACUTE DISEASE; ANTIGENS, CD14; BACTERIAL INFECTIONS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; INFECTIOUS MONONUCLEOSIS; INTERLEUKIN-10; INTERLEUKIN-12; MALE; MONOCYTES; MUCOCUTANEOUS LYMPH NODE SYNDROME; PURPURA, SCHOENLEIN-HENOCH; RECEPTORS, IGG;

EID: 0033856807     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01321.x     Document Type: Article

References (25)

1. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan
2. Pathology of the heart in Kawasaki disease
3. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease
4. Mononuclear cell subsets and coronary artery lesion in Kawasaki disease
5. Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease
6. Immunopathology of the skin lesions of Kawasaki disease
7. Activation of peripheral blood monocytes and macrophages in Kawasaki disease: Ultrastructural and immunohistochemical investigation
8. The monoclonal antimonocyte antibody My4 stains B lymphocytes and two distinct monocyte subsets in human peripheral blood
9. + subpopulation
10. Pediatric rheumatology: Autoimmune mechanisms and therapeutic strategies
11. Interleukin-10 drives human monocytes to CD16 positive macrophages
12. Two distinct pathways of human macrophage differentiation are mediated by interferon-gamma and interleukin-10
13. Expression of FcεR2/CD23 on peripheral blood macrophages/monocytes in Kawasaki disease
14. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-γ in Kawasaki disease involved coronary artery lesions
15. Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease
16. Increased levels of circulating intercellular adhesion molecule-1 in Kawasaki disease
17. Heterogeneity of human blood monocyte: Two subpopulations with different sizes, phenotypes and functions
18. + blood monocytes exhibits features of tissue macrophages
19. Distinct patterns of differentiation induced in the monocytic cell line Mono Mac 6
20. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease
21. Effects of intravenous immunoglobulin on plasma interleukin-10 levels in Kawasaki disease
22. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease
23. Phosphodiesterase inhibitor pentoxifylline: An antiinflammatory/immunomodulatory drug potentially useful in some rheumatic diseases
24. Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: Results from a double-blind, randomized, placebo-controlled study
25. Increased expression of CD23 on peripheral blood B cells and macrophages/monocytes during acute infectious mononucleosis